336 related articles for article (PubMed ID: 19147533)
21. RNA silencing of S-phase kinase-interacting protein 2 inhibits proliferation and centrosome amplification in lung cancer cells.
Jiang F; Caraway NP; Li R; Katz RL
Oncogene; 2005 May; 24(21):3409-18. PubMed ID: 15735730
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of cell proliferation of Tenon's capsule fibroblast by S-phase kinase-interacting protein 2 targeting SiRNA through increasing p27 protein level.
Wang F; Qi LX; Su Y; Yan QH; Teng Y
Invest Ophthalmol Vis Sci; 2010 Mar; 51(3):1475-82. PubMed ID: 19875654
[TBL] [Abstract][Full Text] [Related]
23. E2F-1, Skp2 and cyclin E oncoproteins are upregulated and directly correlated in high-grade neuroendocrine lung tumors.
Salon C; Merdzhanova G; Brambilla C; Brambilla E; Gazzeri S; Eymin B
Oncogene; 2007 Oct; 26(48):6927-36. PubMed ID: 17471231
[TBL] [Abstract][Full Text] [Related]
24. The prognostic value of overexpression of Skp2 mRNA in non-small cell lung cancer.
Takanami I
Oncol Rep; 2005 Apr; 13(4):727-31. PubMed ID: 15756449
[TBL] [Abstract][Full Text] [Related]
25. Analysis of PIK3CA and Akt/protein kinase B in head and neck squamous cell carcinoma.
Fenic I; Steger K; Gruber C; Arens C; Woenckhaus J
Oncol Rep; 2007 Jul; 18(1):253-9. PubMed ID: 17549376
[TBL] [Abstract][Full Text] [Related]
26. Significance of skp2 expression in primary breast cancer.
Sonoda H; Inoue H; Ogawa K; Utsunomiya T; Masuda TA; Mori M
Clin Cancer Res; 2006 Feb; 12(4):1215-20. PubMed ID: 16489076
[TBL] [Abstract][Full Text] [Related]
27. Skp2 overexpression increases the expression of MMP-2 and MMP-9 and invasion of lung cancer cells.
Hung WC; Tseng WL; Shiea J; Chang HC
Cancer Lett; 2010 Feb; 288(2):156-61. PubMed ID: 19625121
[TBL] [Abstract][Full Text] [Related]
28. The molecular role of Fra-1 and its prognostic significance in human esophageal squamous cell carcinoma.
Usui A; Hoshino I; Akutsu Y; Sakata H; Nishimori T; Murakami K; Kano M; Shuto K; Matsubara H
Cancer; 2012 Jul; 118(13):3387-96. PubMed ID: 22028113
[TBL] [Abstract][Full Text] [Related]
29. Stomatin-like protein 2 is overexpressed in cancer and involved in regulating cell growth and cell adhesion in human esophageal squamous cell carcinoma.
Zhang L; Ding F; Cao W; Liu Z; Liu W; Yu Z; Wu Y; Li W; Li Y; Liu Z
Clin Cancer Res; 2006 Mar; 12(5):1639-46. PubMed ID: 16533792
[TBL] [Abstract][Full Text] [Related]
30. A novel gene, RSRC2, inhibits cell proliferation and affects survival in esophageal cancer patients.
Kurehara H; Ishiguro H; Kimura M; Mitsui A; Ando T; Sugito N; Mori R; Takashima N; Ogawa R; Fujii Y; Kuwabara Y
Int J Oncol; 2007 Feb; 30(2):421-8. PubMed ID: 17203224
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of SKP2 promotes the radiation resistance of esophageal squamous cell carcinoma.
Wang XC; Tian LL; Tian J; Jiang XY
Radiat Res; 2012 Jan; 177(1):52-8. PubMed ID: 22077337
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of Aurora-A enhances invasion and matrix metalloproteinase-2 expression in esophageal squamous cell carcinoma cells.
Wang X; Lu N; Niu B; Chen X; Xie J; Cheng N
Mol Cancer Res; 2012 May; 10(5):588-96. PubMed ID: 22522455
[TBL] [Abstract][Full Text] [Related]
33. [Construction of targeting-Skp2 shRNA plasmids and observation of their inhibitory effect on Tca8113 cells].
Fang L; Hu QG; Hua ZC; Li SF
Zhonghua Kou Qiang Yi Xue Za Zhi; 2007 Oct; 42(10):624-8. PubMed ID: 18215375
[TBL] [Abstract][Full Text] [Related]
34. Clinical and prognostic significance of RhoA and RhoC gene expression in esophageal squamous cell carcinoma.
Faried A; Faried LS; Usman N; Kato H; Kuwano H
Ann Surg Oncol; 2007 Dec; 14(12):3593-601. PubMed ID: 17896152
[TBL] [Abstract][Full Text] [Related]
35. HOXA13 promotes cancer cell growth and predicts poor survival of patients with esophageal squamous cell carcinoma.
Gu ZD; Shen LY; Wang H; Chen XM; Li Y; Ning T; Chen KN
Cancer Res; 2009 Jun; 69(12):4969-73. PubMed ID: 19491265
[TBL] [Abstract][Full Text] [Related]
36. SOX2 identified as a target gene for the amplification at 3q26 that is frequently detected in esophageal squamous cell carcinoma.
Gen Y; Yasui K; Zen Y; Zen K; Dohi O; Endo M; Tsuji K; Wakabayashi N; Itoh Y; Naito Y; Taniwaki M; Nakanuma Y; Okanoue T; Yoshikawa T
Cancer Genet Cytogenet; 2010 Oct; 202(2):82-93. PubMed ID: 20875870
[TBL] [Abstract][Full Text] [Related]
37. Gene-expression profile changes correlated with tumor progression and lymph node metastasis in esophageal cancer.
Tamoto E; Tada M; Murakawa K; Takada M; Shindo G; Teramoto K; Matsunaga A; Komuro K; Kanai M; Kawakami A; Fujiwara Y; Kobayashi N; Shirata K; Nishimura N; Okushiba S; Kondo S; Hamada J; Yoshiki T; Moriuchi T; Katoh H
Clin Cancer Res; 2004 Jun; 10(11):3629-38. PubMed ID: 15173069
[TBL] [Abstract][Full Text] [Related]
38. [Effect of Skp2 antisense oligodeoxynucleotide on growth and proliferation of K562 cells].
Wang XZ; Feng WL; Liu X; Cao WX; Huang ZG
Ai Zheng; 2003 Sep; 22(9):948-53. PubMed ID: 12969527
[TBL] [Abstract][Full Text] [Related]
39. PIK3CA and TFRC located in 3q are new prognostic factors in esophageal squamous cell carcinoma.
Wada S; Noguchi T; Takeno S; Kawahara K
Ann Surg Oncol; 2006 Jul; 13(7):961-6. PubMed ID: 16788758
[TBL] [Abstract][Full Text] [Related]
40. A novel target gene, SKP2, within the 5p13 amplicon that is frequently detected in small cell lung cancers.
Yokoi S; Yasui K; Saito-Ohara F; Koshikawa K; Iizasa T; Fujisawa T; Terasaki T; Horii A; Takahashi T; Hirohashi S; Inazawa J
Am J Pathol; 2002 Jul; 161(1):207-16. PubMed ID: 12107105
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
